Role for CD40-CD40 ligand interactions in the immune response to solid tumours

Anton B. Alexandroff, Andrew M. Jackson, T. Paterson, Joanne L. Haley, James A. Ross, D. L. Longo, William J Murphy, Keith James, Dennis D. Taub

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

CD40-mediated interactions play an important role in the response to infections, transplantation, and cancer by affecting the development, activation, proliferation and differentiation of a variety of immune cells. In the current study we examined the role of CD40-mediated interactions in immune responses to bladder, pancreatic and breast carcinomas as well as melanoma cell lines using soluble human CD40L (rhCD40L) or anti-CD40 mAb in vitro. CD40 expression was readily detected in a large proportion of the cell lines and was augmented but not induced de novo by treatment with IFNγ. Treatment of CD40-positive cell lines with rhCD40L or anti-CD40mAb enhanced cell surface expression of ICAM-1 and FAS and stimulated the production of IL-6, IL-8, GROα, GM-CSF and TNFα but not IL-4, IL-10, TGFβ, MCP-1, RANTES, MIP-1β, or IP-10. In addition, incubation of CD40 + tumour cell lines with immobilised rhCD40L or anti-CD40 mAb in vitro resulted in significant inhibition of proliferation and a corresponding decrease in viability. This CD40-mediated inhibition of cell growth was due, at least in part, to alterations in cell cycle and the induction of apoptosis. Transfection of CD40-negative tumour cell lines with the cDNA for CD40 conferred responsiveness to rhCD40L and anti-CD40 antibody. Finally, the presence of CD40 on the surface of carcinoma lines was found to be an important factor in the generation of tumour-specific T cell responses. (C) 2000 Elsevier Science Ltd.

Original languageEnglish (US)
Pages (from-to)515-526
Number of pages12
JournalMolecular Immunology
Volume37
Issue number9
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

CD40 Ligand
Tumor Cell Line
Cell Line
Chemokine CCL5
Neoplasms
Intercellular Adhesion Molecule-1
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-8
Interleukin-4
Interleukin-10
Transfection
Anti-Idiotypic Antibodies
Melanoma
Interleukin-6
Cell Cycle
Urinary Bladder
Complementary DNA
Transplantation
Apoptosis
Breast Neoplasms

Keywords

  • Apoptosis
  • Carcinoma
  • CD40
  • CD40-ligand
  • Melanoma
  • T-lymphocyte

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology

Cite this

Alexandroff, A. B., Jackson, A. M., Paterson, T., Haley, J. L., Ross, J. A., Longo, D. L., ... Taub, D. D. (2000). Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Molecular Immunology, 37(9), 515-526. https://doi.org/10.1016/S0161-5890(00)00079-1

Role for CD40-CD40 ligand interactions in the immune response to solid tumours. / Alexandroff, Anton B.; Jackson, Andrew M.; Paterson, T.; Haley, Joanne L.; Ross, James A.; Longo, D. L.; Murphy, William J; James, Keith; Taub, Dennis D.

In: Molecular Immunology, Vol. 37, No. 9, 2000, p. 515-526.

Research output: Contribution to journalArticle

Alexandroff, AB, Jackson, AM, Paterson, T, Haley, JL, Ross, JA, Longo, DL, Murphy, WJ, James, K & Taub, DD 2000, 'Role for CD40-CD40 ligand interactions in the immune response to solid tumours', Molecular Immunology, vol. 37, no. 9, pp. 515-526. https://doi.org/10.1016/S0161-5890(00)00079-1
Alexandroff AB, Jackson AM, Paterson T, Haley JL, Ross JA, Longo DL et al. Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Molecular Immunology. 2000;37(9):515-526. https://doi.org/10.1016/S0161-5890(00)00079-1
Alexandroff, Anton B. ; Jackson, Andrew M. ; Paterson, T. ; Haley, Joanne L. ; Ross, James A. ; Longo, D. L. ; Murphy, William J ; James, Keith ; Taub, Dennis D. / Role for CD40-CD40 ligand interactions in the immune response to solid tumours. In: Molecular Immunology. 2000 ; Vol. 37, No. 9. pp. 515-526.
@article{85ba285fb49c4db09f22fb236673ef63,
title = "Role for CD40-CD40 ligand interactions in the immune response to solid tumours",
abstract = "CD40-mediated interactions play an important role in the response to infections, transplantation, and cancer by affecting the development, activation, proliferation and differentiation of a variety of immune cells. In the current study we examined the role of CD40-mediated interactions in immune responses to bladder, pancreatic and breast carcinomas as well as melanoma cell lines using soluble human CD40L (rhCD40L) or anti-CD40 mAb in vitro. CD40 expression was readily detected in a large proportion of the cell lines and was augmented but not induced de novo by treatment with IFNγ. Treatment of CD40-positive cell lines with rhCD40L or anti-CD40mAb enhanced cell surface expression of ICAM-1 and FAS and stimulated the production of IL-6, IL-8, GROα, GM-CSF and TNFα but not IL-4, IL-10, TGFβ, MCP-1, RANTES, MIP-1β, or IP-10. In addition, incubation of CD40 + tumour cell lines with immobilised rhCD40L or anti-CD40 mAb in vitro resulted in significant inhibition of proliferation and a corresponding decrease in viability. This CD40-mediated inhibition of cell growth was due, at least in part, to alterations in cell cycle and the induction of apoptosis. Transfection of CD40-negative tumour cell lines with the cDNA for CD40 conferred responsiveness to rhCD40L and anti-CD40 antibody. Finally, the presence of CD40 on the surface of carcinoma lines was found to be an important factor in the generation of tumour-specific T cell responses. (C) 2000 Elsevier Science Ltd.",
keywords = "Apoptosis, Carcinoma, CD40, CD40-ligand, Melanoma, T-lymphocyte",
author = "Alexandroff, {Anton B.} and Jackson, {Andrew M.} and T. Paterson and Haley, {Joanne L.} and Ross, {James A.} and Longo, {D. L.} and Murphy, {William J} and Keith James and Taub, {Dennis D.}",
year = "2000",
doi = "10.1016/S0161-5890(00)00079-1",
language = "English (US)",
volume = "37",
pages = "515--526",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Role for CD40-CD40 ligand interactions in the immune response to solid tumours

AU - Alexandroff, Anton B.

AU - Jackson, Andrew M.

AU - Paterson, T.

AU - Haley, Joanne L.

AU - Ross, James A.

AU - Longo, D. L.

AU - Murphy, William J

AU - James, Keith

AU - Taub, Dennis D.

PY - 2000

Y1 - 2000

N2 - CD40-mediated interactions play an important role in the response to infections, transplantation, and cancer by affecting the development, activation, proliferation and differentiation of a variety of immune cells. In the current study we examined the role of CD40-mediated interactions in immune responses to bladder, pancreatic and breast carcinomas as well as melanoma cell lines using soluble human CD40L (rhCD40L) or anti-CD40 mAb in vitro. CD40 expression was readily detected in a large proportion of the cell lines and was augmented but not induced de novo by treatment with IFNγ. Treatment of CD40-positive cell lines with rhCD40L or anti-CD40mAb enhanced cell surface expression of ICAM-1 and FAS and stimulated the production of IL-6, IL-8, GROα, GM-CSF and TNFα but not IL-4, IL-10, TGFβ, MCP-1, RANTES, MIP-1β, or IP-10. In addition, incubation of CD40 + tumour cell lines with immobilised rhCD40L or anti-CD40 mAb in vitro resulted in significant inhibition of proliferation and a corresponding decrease in viability. This CD40-mediated inhibition of cell growth was due, at least in part, to alterations in cell cycle and the induction of apoptosis. Transfection of CD40-negative tumour cell lines with the cDNA for CD40 conferred responsiveness to rhCD40L and anti-CD40 antibody. Finally, the presence of CD40 on the surface of carcinoma lines was found to be an important factor in the generation of tumour-specific T cell responses. (C) 2000 Elsevier Science Ltd.

AB - CD40-mediated interactions play an important role in the response to infections, transplantation, and cancer by affecting the development, activation, proliferation and differentiation of a variety of immune cells. In the current study we examined the role of CD40-mediated interactions in immune responses to bladder, pancreatic and breast carcinomas as well as melanoma cell lines using soluble human CD40L (rhCD40L) or anti-CD40 mAb in vitro. CD40 expression was readily detected in a large proportion of the cell lines and was augmented but not induced de novo by treatment with IFNγ. Treatment of CD40-positive cell lines with rhCD40L or anti-CD40mAb enhanced cell surface expression of ICAM-1 and FAS and stimulated the production of IL-6, IL-8, GROα, GM-CSF and TNFα but not IL-4, IL-10, TGFβ, MCP-1, RANTES, MIP-1β, or IP-10. In addition, incubation of CD40 + tumour cell lines with immobilised rhCD40L or anti-CD40 mAb in vitro resulted in significant inhibition of proliferation and a corresponding decrease in viability. This CD40-mediated inhibition of cell growth was due, at least in part, to alterations in cell cycle and the induction of apoptosis. Transfection of CD40-negative tumour cell lines with the cDNA for CD40 conferred responsiveness to rhCD40L and anti-CD40 antibody. Finally, the presence of CD40 on the surface of carcinoma lines was found to be an important factor in the generation of tumour-specific T cell responses. (C) 2000 Elsevier Science Ltd.

KW - Apoptosis

KW - Carcinoma

KW - CD40

KW - CD40-ligand

KW - Melanoma

KW - T-lymphocyte

UR - http://www.scopus.com/inward/record.url?scp=0034546367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034546367&partnerID=8YFLogxK

U2 - 10.1016/S0161-5890(00)00079-1

DO - 10.1016/S0161-5890(00)00079-1

M3 - Article

C2 - 11163401

AN - SCOPUS:0034546367

VL - 37

SP - 515

EP - 526

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 9

ER -